This consultation closed on 3 May 2022
Consultation period5 April 2022 to 3 May 2022
The APVMA is considering an application for registration of the product Xivana Prime 20 SC Fungicide containing 20 g/L of the new active constituent fluoxapiprolin, as a suspension concentrate (SC) formulation. The product is intended for the control of Downy mildew (Plasmopara viticola) in grapevines.
We invite comment from 5 April 2022 to 3 May 2022 on whether approval of the active constituent and registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds, including:
- occupational health and safety
- public health
- chemistry and manufacture
- residues in food
- environmental safety
- efficacy and target crop safety.
Download the Public Release Summary on the evaluation of Xivana Prime 20 SC Fungicide.
For more information see page 30, APVMA Gazette No. 7, 5 April 2022
Please note: Submissions will be published on the APVMA’s website unless you have asked for the submission to remain confidential (see public submission coversheet).
Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.
Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission by email, post or fax to:
Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Phone: +61 2 6770 2300
The APVMA sought comments from interested stakeholders on fluoxapiprolin in the product Xivana Prime 20 SC Fungicide, in a consultation that closed on 3 May 2022.
No submissions were received. We have finalised registration of the product.